Search & Analyze
Popular Searches
Orchid Pharma Ltd.
Healthcare₹992.004.14%
24 Jul, 4:01 PM
CMP₹992.00
Mkt Cap₹4.88K Cr
P/E237.71
P/B3.79
ROE7.86%
52W High₹1,120.00
52W Low₹471.30
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
237.71
P/B Ratio
3.79
EV/EBITDA
67.61
Price/Sales
6.02
Dividend Yield (%)
0.00
EPS (TTM ₹)
4.05
Book Value (₹)
253.91
ROE (%)
7.86
ROCE (%)
8.05
ROA (%)
5.91
EBITDA Margin (%)
12.00
Net Profit Margin (%)
10.39
Debt/Equity
0.14
Current Ratio
2.83
Interest Coverage
7.40
Asset Turnover
0.57
Working Capital/Sales
1.77
Core EBITDA Growth (%)
2.20
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 45006.04 | 55955.74 | 66589.84 | 81936.82 | 92192.59 |
| Net Sales | 45006.04 | 55955.74 | 66589.84 | 81936.82 | 92192.59 |
| Total Income | 46527.2 | 56856.03 | 68532.89 | 85049.61 | 95637.22 |
| Total Expenditure | 39939.81 | 50497.84 | 58160.34 | 70857.82 | 81132.74 |
| Operating Profit | 6587.39 | 6358.19 | 10372.55 | 14191.79 | 14504.48 |
| Depreciation | 10891.64 | 8702.46 | 5478.68 | 3323.71 | 3454.58 |
| Exceptional Items | — | — | 3921.04 | — | — |
| Profit Before Tax | -9524.89 | -5689.87 | 5524.69 | 9194.52 | 9556.48 |
| Tax | — | — | — | -311.91 | -19.35 |
| Profit After Tax (PAT) | -9524.89 | -5689.87 | 5524.69 | 9506.43 | 9575.83 |
| EPS (₹) | -28.55 | -0.48 | 11.35 | 19.06 | 19.65 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 4081.64 | 4081.64 | 4081.64 | 5071.91 | 5071.91 |
| Reserves | 61209.14 | 60656.35 | 64783.26 | 111874.7 | 121656.63 |
| Shareholders Funds | 65290.78 | 64737.99 | 68864.9 | 116946.61 | 126728.54 |
| Total Debt | 45274 | 26795.36 | 33134.57 | 13447.73 | 17423.91 |
| Total Liabilities | 123725.21 | 111056.25 | 122520.63 | 155387.39 | 168781.35 |
| Total Assets | 123725.21 | 111056.25 | 122520.63 | 155387.39 | 168781.35 |
| Book Value / Share | 159.9621 | 158.6078 | 168.7187 | 230.5771 | 249.8635 |
| Assets | 123725.21 | 111056.25 | 122520.63 | 155387.39 | 168781.35 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 2358.6 | 9247.46 | 1833.8 | 12599.2 | 1921.51 |
| Investing Activities | 6720.51 | 11293.62 | -3121.39 | -31202.86 | -2693.17 |
| Financing Activities | -16498.87 | -21679.81 | 3116.64 | 16704.04 | 2522.17 |
| Net Cash Flow | -7419.76 | -1138.73 | 1829.05 | -1899.62 | 1750.51 |
ORCHPHARMA
₹992.00
+4.14%